In in vitro experiments, we show that the sensitivity of CAMTA1-overexpressed colorectal cancer cells to oxaliplatin was increased, whereas that of CAMTA1-silenced cells to oxaliplatin was decreased, indicating that CAMTA1 promotes the death of colorectal cancer cells exposed to this drug. The gene discussed is CAMTA1; the disease is colorectal cancer.